Sonoma Pharmaceuticals Announces Termination of Executive Vice President

TradingView
2025.10.23 21:05
portai
I'm PortAI, I can summarize articles.

On October 18, 2025, Sonoma Pharmaceuticals, Inc. announced the immediate termination of Bruce Thornton as Executive Vice President and Chief Operating Officer for cause, as per his employment agreement. Replacement information has not been disclosed. This announcement was filed with the SEC under the original filing number SNOA - 8-K on October 23, 2025.

On October 18, 2025, Sonoma Pharmaceuticals, Inc. announced the termination of Bruce Thornton as Executive Vice President and Chief Operating Officer, effective immediately. The termination was for cause as per his employment agreement.

IndividualBruce Thornton
RoleExecutive Vice President and Chief Operating Officer
Type of ChangeTerminated
Effective DateOctober 18, 2025
ReasonFor cause
Replacement InfoNot disclosed
Background DetailsN/A
Board/Committee Role ChangesNot disclosed

Original SEC Filing: Sonoma Pharmaceuticals, Inc. [ SNOA ] - 8-K - Oct. 23, 2025

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer